Global Biomarker technologies Market is valued at USD 42.8 billion in 2016 is anticipated to grow USD 96.8 billion with the compounded annual growth of 9.7% over the forecast period 2017-2025.
New York 28 June 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Biomarker technologies industry is poised to raise USD 96.8 billion by 2025. Some key components for the market development will be; increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries, the high prevalence of cancer, and new initiatives for biomarker research.
To view the summary or to request a sample copy of this report, please click the link mentioned below:
Global Biomarker technologies Market Size study, by Product (Consumables, Service), by Type (Safety, Efficacy, Validation), by Disease Indication (Cancer, Cardiovascular Disorders), by Application (Diagnostics Development, Drug Discovery, and Development, Disease-Risk) and by Regional Forecasts 2017-2025.
The industry seems to be fairly competitive. Some of the leading market players include Qiagen N.V., Perkinelmer Inc., Merck Millipore, Bio-Rad Laboratories Inc., Enzo Biochem Inc, and so on. Other market players discussed in the report include Biosims technologies SaS, Cisbio Bioassays. New product launches, acquisitions, and mergers are some of the strategies adopted by the key manufacturers. Additionally, the fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Key findings of the study:
- Increase in R&D spending for biomarker research and development and technological advancements are driving the growth of the market.
- Increasing use of biomarkers for diagnostic purposes, increasing incidence of chronic diseases are driving the growth of the market in Asia.
- Increasing outsourcing of pharmaceutical R&D activities to outsourcing partners in Asia is driving the growth of the market in Asia.
Bizwit Research & Consulting LLP has considered following segments for the study:
By Disease indication:
- Cardiovascular disorders
- Diagnostics development
- Drug discovery and development
- Disease risk
- North America
- Asia Pacific
- Latin America
- Rest of the World